New Insights II Inc at a Glance
Day treatment in Lemoyne, PA. Payment options listed: Medicaid, private insurance, self-pay and sliding fee scale.
New Insights II Inc is located in Lemoyne, Pennsylvania, and provides outpatient substance use treatment for young adults and adults, serving both men and women. The program offers outpatient and intensive outpatient care, along with partial hospitalization, and it uses medications including buprenorphine and naltrexone as part of treatment. Payment options include Medicaid, private insurance, self-payment, and a sliding fee scale.
It is licensed by the state.
Licence and Status Details
No licence details have been independently confirmed here. Request the license details from the facility and verify them with the licensing authority.
Active
Services Listed for New Insights II Inc
Here is what New Insights II Inc offers for care options, in plain terms.
Types of Care
- Substance use disorder treatment
- Partial hospitalization (day treatment)
- Intensive outpatient
- Outpatient
- Buprenorphine
- Naltrexone
- Medication for alcohol use disorder
Groups Served
- Young adults
- Adults
- Women
- Men
Ways to Pay
- Medicaid
- Private insurance
- Self-pay
- Sliding fee scale
Licensing and Accreditation
- Holds a state licence, certification or accreditation
These services come from the facility's own report to SAMHSA's treatment locator. Check with the facility before you go.
Where New Insights II Inc Is and How to Get There
Here is where New Insights II Inc is and how to reach it.
716 State Street, Lemoyne, PA, 17043
Help Choosing Between Programs
A directory listing helps you compare options but is only a starting point: contact the facility to confirm its services, admission requirements and availability. Being listed is neither an endorsement nor a guarantee of admission.
What to Ask New Insights II Inc First
Ask which services are offered, who delivers the care, how admission works and whether there is a wait. Check the full cost, how insurance is handled and any extra charges with the facility itself.